Inventor
Craig A. Smith
Inventor
Seattle, WA, US
Overview
Patents· 35 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides28%
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
A61BDiagnosis4%
A61MDevices for introducing media into, or onto, the body4%
C12NMicroorganisms or enzymes4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
C07DHeterocyclic compounds2%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry1%
PatentTitleYear
8,377,448'CD47 related compositions and methods for treating immunological diseases and disorders'20138,293,500'Methods for identifying polypeptide targets and uses thereof for treating immunological diseases'20128,106,201'Process for the synthesis of morphinane compounds and intermediates thereof'20127,875,718'Process for the synthesis of morphinane compounds and intermediates thereof'20117,459,528'Glycoproteins which bind to TNF'20087,232,660'CD30 ligand'20077,211,259'4-1BB polypeptides and DNA encoding 4-1BB polypeptides'20077,138,500'Antibodies to human 4-1BB'20067,057,022'Antibodies which specifically bind to TNF-R'20066,852,486'Viral proteins capable of binding LAR'20056,667,039'CD30 ligand'20036,572,852'Method for suppressing inflammatory responses by administering TNFR'20036,541,610'Fusion proteins comprising tumor necrosis factor receptor'20036,524,298'Therapeutic and diagnostic agent delivery'20036,355,779'Cytokine designated 4-1BB ligand antibodies and human receptor that binds thereto'20026,224,867'Tumor necrosis factor-.alpha. and -.beta. receptors'20016,224,584'Therapeutic and diagnostic agent delivery'20016,201,105'Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)'20016,143,869'CD30 ligand oligomers and polypeptides'2000RE036755'DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors'20005,997,525'Therapeutic and diagnostic agent delivery'19995,945,397'Purified p75 (type II) tumor necrosis factor receptor polypeptides'19995,871,740'Methods of using poxvirus p35 as a chemokine inhibitor and compositions therefore'19995,840,059'Therapeutic and diagnostic agent delivery'19985,753,203'CD30 ligand conjugates'19985,712,155'DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors'19985,677,430'Antibodies directed against CD30 ligand'19975,674,704'Cytokine designated 4-IBB ligand'19975,605,690'Methods of lowering active TNF-.alpha. levels in mammals using tumor necrosis factor receptor'19975,589,456'Granulocyte-colony stimulating factor receptors'19965,480,981'CD30 ligand'19965,464,938'Isolated viral protein TNF antagonists'19955,422,248'DNA sequences encoding granulocyte-colony stimulating factor receptors'19955,395,760'DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors'19955,359,039'Isolated poxvirus A53R-equivalent tumor necrosis factor antagonists'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994–2008Patents assigned to IMMUNEX CORP (25)· patent assignee history
1994–2013Based in Seattle, WA, US· patent location history
1998–2003Patents assigned to CARDIOGENESIS CORP (3)· patent assignee history
1998–2003Based in Bronxville, NY, US· patent location history
2011–2012Patents assigned to GLAXOSMITHKLINE AUSTRALIA PTY LTD (2)· patent assignee history
2011–2012Patents assigned to JOHNSON MATTHEY PLC (2)· patent assignee history
2011Based in Port Fairy, AU· patent location history
2012–2013Patents assigned to KAYKAS AJAMETE (2)· patent assignee history
2012Based in Melbourne, AU· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMUNEX CORP | 25 | 1994–2008 |
| CARDIOGENESIS CORP | 3 | 1998–2003 |
| GLAXOSMITHKLINE AUSTRALIA PTY LTD | 2 | 2011–2012 |
| JOHNSON MATTHEY PLC | 2 | 2011–2012 |
| KAYKAS AJAMETE | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Seattle, Washington, US | 29 | 1994–2013 |
| Bronxville, New York, US | 4 | 1998–2003 |
| Melbourne, AU | 1 | 2012 |
| Port Fairy, AU | 1 | 2011 |